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 Treatment integrity is a critical component in ensuring that any protocol is 
implemented as it is planned.  Unfortunately it is not a variable that has been recorded very 
often in the field of Behavior Analysis.  Protocols that are not implemented with high 
integrity threaten the validity and outcome of the protocol.  This review replicated the study 
of Gresham, Gansle, and Noell (1993) and coded all of the articles with children as subjects 
between the years of 1991 and 2010 and published in the Journal of Applied Behavioral 
Analysis.  The protocol was modified slightly to allow for the incorporation of the variables: 
location, article type, presence of disabilities. The results showed that only 33.3% of all of 
the articles that fit the inclusion criteria for this study reported data on treatment integrity.  
The shocking lack of growth in awareness for the importance of treatment integrity in the 
years after Gresham’s (1993) study has huge implications for the state of validity in Behavior 
Analysis.  Treatment integrity is an important factor in Applied Behavior Analysis because 
protocols that are implemented with high integrity have a more effective outcome than 
studies which do not provide data on treatment integrity.  This study may help further 
awareness for the importance of the collection of treatment integrity data in protocols 
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Treatment integrity, also called treatment fidelity, or procedural integrity is defined as 
the degree to which a treatment is implemented as planned (Fiske, 2008).  It is a factor that is 
important across all fields, but especially so in medical and behavioral sciences.  Without 
integrity, there would be no consistency within or between treatment protocols or among 
those individuals implementing treatments.   
Applied Behavior Analysis (ABA) uses learning techniques in order to cause a 
change in behavior.  The term treatment integrity, is a term specific to the field of ABA.  As 
defined by Gresham, Gansle, and Noell , treatment integrity is, “ The degree to which an 
independent variable is implemented as intended…” (1993). Treatment integrity is important 
for a variety of reasons that will be covered below.  
McIntyre, Gresham, DiGennaro, and Reed (2007) explained the importance of 
treatment integrity and stated that incorrectly following protocols could result in poor 
outcomes.  For example, if a researcher was asked to follow a protocol that has 4 parts and 
the researcher forgot to implement one of the parts or implemented them in the wrong order, 
the procedure would be thought to have poor integrity.  Poor integrity would jeopardize the 
reliability of the procedure, not to mention, the outcome.  Another example of procedural 
integrity is in medicine.  Procedural fidelity is an especially important factor in medicine 
because it is imperative to ensure that all procedures are performed as they were intended to 
be performed and also executed consistently by all treatment providers.  Without treatment 





come away from the hospital in worse shape than when the patient initially reached there.  
The examples show just how important it is to have integrity present in all fields.   
Although applicable to everything from education to mechanics, treatment integrity is 
a variable that is especially important in the field of behavioral science where the protocols 
followed with high integrity produce the strongest outcomes (Fiske, 2008).   However, 
treatment integrity is a factor that is often overlooked by behavioral researchers.  Gresham, 
Gansle, and Noell (1993) found that only 16% of studies pertaining to Applied Behavior 
Analysis (ABA) and children done between 1980 and 1990 reported data on treatment 
integrity.  Out of the 158 studies that were included in this study, this is infact a very small 
percentage of articles. Gresham, Gansle, and Noell (1993) analyzes articles pertaining to 
ABA with children (defined as individuals under 19 years of age) and published in the 
Journal of Applied Behavioral Analysis (JABA) between the years of 1980 and 1990.  These 
articles were coded to check for the reporting of treatment integrity data in the studies that 
met their inclusion criteria.   
The purpose of the current study was to replicate the protocol established by Gresham 
el at (1993) and examine the trends of reporting treatment integrity in research studies with 
children between 1991 and 2010 and published in the JABA.  The study also analyzes the 
correlation between treatment integrity and the location of the studies to determine whether 
there was a tendancy to over or under report integrity data based on setting.  After Gresham, 
Gansle and Noell’s study (1993), the aim of this study is to analyze the trends in the 
collection of treatment integrity data in Applied Behavior Analysis, as well as to call 
attention to the importance of treatment integrity in ABA and to urge researchers to collect 






 Treatment integrity is the extent to which a protocol has been implemented as it was 
intended to be implemented (Fiske, 2008).  The lack of information about treatment integrity 
in a study leads to difficulties in making correct conclusions about the data (Sanetti, 2009).  
Treatment integrity is crucial to all fields of research because it ensures that a particular 
procedure is being executed by the means it was intended to be implemented.  Without 
treatment integrity, not only are we unable to draw accurate conclusions, but we also lose a 
factor of validity to the research (Wheeler, Mayton, Carter, Chitiyo, Mendez, & Huang, 
2009).  Treatment integrity is the essential factor in ensuring that the best desired outcome is 
reached via the proper implementation of the protocol.  The concept of treatment integrity 
applies across all fields and provides many implications as far as the safety and validity of 
human subject procedures and research.   
 Medicine is a key example of a field that revolves around treatment integrity.  
Without safety protocols in place in medicine, there would be no consistency between 
treatment providers, which is a startling realization.  In 2008, the World Health Organization 
started an initiative called the “Safe Surgery Saves Lives” campaign, which developed a 
checklist for integrity during invasive procedures (Marjot, Maruthappu, & Shalhoub, 2013).  
This checklist was well received by the operating room staff and reduced morbidity and 
mortality, but unfortunately it did not generalize well outside of the operating room because 
the procedures were not followed by medical staff in other medical settings (Marjot et al., 
2013).  During invasive procedures conducted in settings outside of the operating room (such 
as labs and clinics), 10% of patients experienced adverse reactions, 40% of which were 





leading to preventable complications (Marjot et al., 2013).  This is an example of treatment 
integrity generalized to fields outside of Behavior Analysis because it shows how a 
procedure with high integrity leads to a reduced risk of adverse reactions.  In the medical 
example, when the procedure was not followed with high integrity, the result was adverse 
reactions to an improperly implemented procedure.   
The medical example above shows how critical treatment integrity is to the correct 
implementation of a procedure.  In the example, the presence of treatment integrity checks in 
the operating room and the lack of treatment integrity checks in other settings were the 
difference between the best positive outcome and complications due to incorrect 
implementation of the protocol.  Fortunately, hospitals and clinics have many procedural 
integrity checks in place in order to ensure correct implementation of procedures.   
 Similar to medicine, treatment integrity plays a crucial role in the field of ABA. This 
is because treatment integrity strengthens the effects of intervention, which means that higher 
integrity will produce more positive results (Fiske, 2008).  It is important to have high 
integrity when implementing behavioral protocols because having low integrity and a lack of 
consistency between treatments or between researchers will most likely lead to negative 
results.  Weiss states that it is important to check integrity on a regular basis in order to 
ensure the highest quality of treatment, and therefore the most positive outcome possible 
(2005).  Regular integrity checks are important to conduct because they ensure that the 
protocol is constantly being implemented with high integrity.  
Treatment integrity reporting is often a neglected area of research even though 
researchers have brought attention to the importance of collecting treatment integrity data 





between higher treatment integrity and improved treatment (2012).  In 1982, Peterson et al 
found that a large number of cases between the years of 1968 and 1980 did not provide any 
measure of treatment integrity.  Unfortunately this is not a fact that has changed much since 
that time.   
In a study conducted by Wheeler et at (2006), 18% of the studies conducted with 
children with autism provided a measure for treatment integrity.  This is a worrisome result 
as it shows that there was not much evidence for consistency in the implementation of 
protocols in the field.  Also, it is surprising to find such a lack of data on treatment integrity 
when studies by Peterson et al (1982), Gresham, Gansle, and Noell (1993) and Wheeler et al 
(2006), that all report a measure of integrity under 20% of the total number of studies 
included in their reports.  More surprising is that there are a number of methods for collecting 
treatment integrity data, all of which are fairly simple, and include methods such as self-
reporting, feedback from observers, videotaping of the session, and direct observation (Lane, 
Bocian, MacMillan, & Gresham, 2004; Weiss, 2005).  Still, there is such a lack of treatment 
integrity measures reported in ABA.  Unfortunately, treatment integrity is not reported as 
commonly as it should be (McIntyre et al., 2007) and has especially been overlooked in the 
field of ABA (McIntyre et al., 2007; Peterson, Homer, & Wonderlich, 1982; Wheeler, 
Baggett, Fox, & Blevins, 2006).  Wheeler et al. makes the claim that, “…the field needs to be 
more steadfast in promoting the inclusion of treatment integrity measures in behavioral 
treatment measures…” (2009).  Weiss states that treatment integrity should be evaluated on 
an ongoing basis to ensure that, over time, trained treatment providers maintain a particular 






All of the articles being reviewed were published in the Journal of Applied Behavior 
Analysis (JABA) between the years of 1991-2010.  This study is a replication and 
continuation of the study done by Gresham, Gansle, and Noell published in 1993.  The 
methodology for this study was taken from the protocol provided in the Gresham study and 
modified in order to analyze different variables that could be of significance.   
Criteria for Review 
Studies that were included in this review were based on the following criteria: Both 
research and brief reports were included in the review. Brief reports were defined as three or 
fewer pages, and a research report was defined as anything greater than three pages in length.  
The population studied was children, defined as those individuals 19 years or younger; and 
the date of publication in JABA was 1991-2010.   
Coding Procedure 
The studies that fit the criteria were coded on the basis of these 5 variables: (1) age; 
(2) location of the study; (3) if the participants had disabilities (which included all mental and 
intellectual diagnoses); (4) type of report (brief or research); (5) and assessment of treatment 
integrity.  Age was recorded as it was reported in the studies.  Location data was recorded 
based on four categories: Home, school, clinical (which included all medical and non 
medical based treatment facilities), and other (which included community sessions, sports 
practices off of the school premises and when a study was conducted in more than one 
location).  Disabilities were coded as ‘yes’ or ‘no’ and included all physical and intellectual 





no; and (3) monitored; following the coding strategy used by Gresham, Gansle, and Noell 
(1993).  A checklist of the coding procedure can be found in Appendix 1.  
Treatment integrity 
If a study provided information on integrity and reported numbers or percentages of 
integrity, it was coded as yes.  Studies that provided protocols and information on how and to 
what extent the integrity protocols were implemented were also coded as yes.  If a study 
provided no mention of integrity or provided no results on integrity, it was coded as no.  If a 
study mentioned integrity but did not report the results of integrity checks, or said that the 
integrity data are provided elsewhere, it was coded as monitored.  
Results 
From 1991-2010, 652 articles met the criteria for inclusion for this study.  On 
average, there were 32 articles children as the subjects published each year between 1991 and 
2010, with the least being 17 studies in 1991 and the most being 45 studies in 2010.  Of the 
studies that were published during this time, 33.2% (N=213) reported data on treatment 
integrity.  During this time 38.3% (N=246) did not provide measure of treatment integrity.  
The remaining 30.1% (N=193) of the studies fell into the monitored category, which meant 
that treatment integrity was mentioned in the study but no data were provided. 
The data are included in Tables 1 and 2.  Table 2 shows the data reported by 
Gresham, Gansle, and Noell (1993) and Table 1 shows data from the current study.  The 
trends in integrity data from 1980-2010 can be seen in Figures 1 and 2 which graphically 
represent the data of Gresham, Gansle, and Noell continuing into the data from this study.  
Figures 3 and 4 show data on treatment integrity in relation to the location of the studies.  





reported.  Figures 6 and 7 show the data collected by Gresham and his colleagues (Table 2) 
in a graphical manner.  
Table 1. Table presented in Gresham , Gansle, and Noell (1993). All of the data is presented 
as a percentage of the number of studies for each year.  (The raw numbers were not provided 
in the Gresham, Gansle, Noell study (1993).  
Year yes No Modified Combined 
1980 18.20% 72.70% 9.10% 81.80% 
1981 17.60% 76.60% 5.90% 82.50% 
1982 11.10% 83.30% 5.60% 88.90% 
1983 37.50% 50.00% 12.50% 62.50% 
1984 13.30% 73.30% 13.30% 86.60% 
1985 0.00% 100.00% 0.00% 100.00% 
1986 15.00% 75.00% 10.00% 85.00% 
1987 7.70% 61.50% 30.80% 92.30% 
1988 25.00% 75.00% 0.00% 75.00% 
1989 10.00% 80.00% 20.00% 100.00% 
1990 13.30% 86.70% 0.00% 86.70% 
Note: The combined no/monitored category is also present in this table in the starred no 
category at the end.  This table is the same table that was provided in the Gresham, Gansle, 
Noell study (1993) with the addition of the combined no/monitored category at the end.  It 
shows the percentages of treatment integrity data that was reported in the articles included in 
their study.   
Table 2. Data in percentages and numbers for the current study: 1991-2010 with “yes”, 
“no”, “monitored”, and combined no/monitored categories.  This table shows the number of 
studies in each category: Yes, No, and Monitored, as well as the percentages of the total 
number of studies for each year.   
Year Yes % Yes No % No Monitored % Monitored Combined No* % Combined No 
1991 13 76.5% 1 5.9% 3 17.6% 4 23.5% 
1992 19 61.3% 3 9.7% 9 29.0% 12 38.7% 
1993 12 50.0% 7 29.2% 5 20.8% 12 50.0% 
1994 17 51.5% 4 12.1% 12 36.4% 16 48.5% 
1995 9 36.0% 6 24.0% 10 40.0% 16 64.0% 
1996 9 26.5% 13 38.2% 12 35.3% 25 73.5% 
1997 16 43.3% 12 32.4% 9 24.3% 21 56.7% 





1999 8 38.1% 4 19.1% 9 42.8% 13 61.9% 
2000 9 26.5% 12 35.3% 13 38.2% 25 73.5% 
2001 6 18.8% 13 40.6% 13 40.6% 26 81.2% 
2002 7 25.9% 7 25.9% 13 48.2% 20 74.1% 
2003 8 29.6% 9 33.3% 10 37.1% 19 70.4% 
2004 5 15.2% 13 39.4% 15 45.4% 28 84.8% 
2005 6 17.6% 22 64.7% 6 17.7% 28 82.4% 
2006 7 21.9% 21 65.6% 4 12.5% 25 78.1% 
2007 12 27.3% 24 54.5% 8 18.2% 32 72.7% 
2008 11 30.4% 16 47.6% 8 22.0% 24 69.6% 
2009 16 30.7% 24 46.2% 12 23.1% 36 69.3% 
2010 15 33.4% 20 44.4% 10 22.2% 30 66.6% 
 Note: This table reports the data from the replication.  It reports the number of studies per 
year that were recorded in each category: Yes, no, and monitored.  It also presents the data as 
percentages of the number of studies per year.  The last two columns present the number of 
the studies and the percentage of total studies per year, respectively, with a combined 
no/monitored category. 
 
Figure 1. Continuation graph presented with a phase line between the Gresham data and the 
new data.  The portion of this figure before the phase change line shows a graphical 






































Data  of Treatment Integrity for 1980-1991 (Gresham et al) 









Noell study (1993).  The “yes” line represents the percentage of the total number of studies 
that reported integrity data.  The “no” line represents the percentage of the total number of 
studies that did not provide any information on treatment integrity in their study.  The 
“monitored” line represents the percentage of the total number of studies that were 
considered to be in the monitored category.  Studies in this category provided little 
information on integrity or had integrity data/protocols that were accessible from sources 
outside of the study (e.g. from the first author).  The portion of the graph following the phase 
change line represents the data collected in this study, according to the same classifications.   
 When the “no” and “monitored” categories were combined into a broader “no” 
category, 33.2% of the studies reported integrity data while 68.4% of the studies did not.  
Figure 2 shows this new categorization of the Gresham data followed by the data from this 
study.   
 
Figure 2.  Continuation graph presented with a phase line between the Gresham data and the 
new data where the “monitored” and “no” categories are both represented by the “no” line.  
The portion of data before the phase change line presents the data reported by Gresham as a 
percentage of the total number of studies, but shows the data for the “no” and “monitored” 












































Data  of Treatment Integrity for 1980-1991 (Gresham et al) and for 
1991-2010 (current study) 
with a combined "No" category 
Yes 
no 





from this study in percentages of the total number of studies.  The “monitored” and “no” 
categories were combined into one “no” category for this as well.  
Both Figure 1 and Figure 2 show a spike in the reporting of integrity data following 
Gresham’s study, with an immediate decline in the years following with a slight upward 
trend in the most recent years.  One potential reason for this spike in the reporting of 
treatment integrity between the years of 1991-1993 could be that treatment integrity could 
have been a topic at an ABA conference during this time.   
Location data showed that studies conducted in a school or classroom setting most 
often collected and reported integrity data. Of the studies conducted in a school setting 41.4% 
reported integrity data.  There were integrity data reported for 24.6% of studies conducted in 
a clinical setting, 32.8% of studies conducted in a home setting, and 28% of studies 
conducted in other or a combination of settings.  For 43.8% of clinical studies, 43.1% of 
home studies, 30.8% of school studies, and 40.2% of other settings, there was no integrity 
data or protocol reported. The remaining 31.7% of studies in the clinical setting, 24.1% of 
studies in the home setting, 27.8% of studies in the school setting, and 31.7% of studies in 
other settings or a combination of settings fell into the monitored category where integrity 
was mentioned but there was no data reported on it (Figure 3).  When the “no” and the 
“monitored” categories were combined into a broader “no” category, 75.4% of clinical 
studies, 67.2% of home studies, 58.6% of school studies, and 72% of studies in other or a 
combination of locations were considered to not provide integrity data (Figure 4).  Location 
data was not provided by Gresham , Gansle, and Noell (1993) so the figures only include 







Figure 3. Graph of integrity data and the locations where the studies were conducted.  The 
graph shows the percentage of the total number of studies presented in terms of location.  
The location data was not collected in the initial Gresham study but was collected for the 
purposes of this study.  This graph shows how the three categories of integrity were 
represented across various locations.  
 
Figure 4. Graph of integrity data and the locations where the studies were conducted with a 
combined no category.  This graph represents the percentage of the total number of studies in 

















































































Integrity Data Reported in Relation to Location with a 







The data from the current study are also shown as a cumulative frequency in Figure 5.  
Cumulative frequency graphs show the rate at which there is change in a category.  The 
results for this study showed that there was a much more rapid change in the “no” category 
than there was in the “yes” category.  This graph showed a much steeper rise in the “no” 
category, with a slope of m=22.5 while the “yes” category had a much shallower rise with a 
slope of m=9.21.  The data for this graph was calculated by adding each successive year 
worth of data together in order to achieve a graph that depicts rate.  The slope was calculated 
by using a line of best fit though Excel.    
 
Figure 5. Cumulative Frequency graph representing the data in two categories: Yes and no.  
This graph presents the data from the current study in the form of cumulative frequency 
graph which allows the data to be seen as change over time.  The data is presented as “yes” 
and “no”, where “yes” is made up of studies that reported treatment integrity and “no” 
consists of all of the studies in the original “no” and “monitored” categories.  The graph 
shows the slopes of these data and represents the rate of the occurrence of these conditions. 
Discussion 
The study by Gresham , Gansle, and Noell (1993) brought to light the importance of 
treatment integrity in procedures done with children and showed how an astonishing number 
y = 9.2316x - 18351 
 



































of researchers have not been conducting integrity checks to ensure that their protocols were 
being implemented as intended.  The lack of procedural integrity checks could mean that 
protocols could have been implemented incorrectly, leading potentially, to a negative 
outcome.  The results of the current study show that despite Gresham’s efforts, treatment 
integrity data are still not consistently recorded in studies conducted with children, which 
implies that the importance of treatment integrity may still be a factor that many researchers 
do not fully understand the importance of or see as an optional variable when implementing a 
protocol.   
  Following the Gresham, Gansle, and Noell (1993) study which could have been due 
similar publication on the importance of treatment integrity to have been published around 
this time.  Immediately after the publication of the Gresham, Gansle, and Noell (1993) study, 
we see a large decline in the reporting of integrity and large upward trend in the “no” 
category.  This is a surprising trend, especially when considering that the desired and 
anticipated aftereffects of Gresham’s study would have been to see a steady upward trend in 
the reporting of integrity data in studies conducted with children in JABA.   This shows that 
the Gresham study did not have the lasting results they had hoped for but instead may have 
had a temporary effect in the years surrounding the conduction of the study.  The Gresham 
study was first received by JABA in 1992, and although published in late 1993, it is possible 
that the results of the study could have been released into the scientific community before 
this time.  It is also possible that treatment integrity could have been a topic at ABA 
conferences during this time frame which could explain the short increase in the reporting of 





 The results also showed that despite Gresham’s study (1993), there has not been a 
change in the reporting of integrity data in JABA articles since 1990.  The immediate increase 
in reporting of integrity data was followed by a decrease that eventually leveled off to a level 
close to the levels reported in Gresham’s study ,  although the percentage of “no” data 
remained lower  in this study than in the original study.  This could largely have to do with 
the number of journal articles included in each study.  The Gresham study included 158 
articles that fit the inclusion criteria while this study included 653 articles.  Just the vast 
difference in the numbers of studies could have made a difference on the overall data. Also, 
the difference in number of articles included from each year could have affected the data.  
The percentages for each year were reported out of the total number of articles that met the 
inclusion criteria for that year.  There were fewer articles that met the inclusion criteria in the 
years where the “yes” data spiked than there were in the years towards the end of the range.  
Similarly, there were fewer articles per year published in the Gresham, Gansle, and Noell 
(1993) study than in this study, with an average of 14 articles per year in Gresham and 33 
articles per year in this study.   
 The data reported by Gresham, Gansle, and Noell (1993) was graphed side by side 
with the data from this study in a category combining “no” and “monitored” into one broad 
“no” category.  The effect of the combined category can be seen in the figures presented in 
the results (Figure 1; Figure 2).  This was not a factor that was analyzed in the study done by 
Gresham, Gansle, and Noell (1993) but was added in this study because the importance of 
the “monitored” category was questionable.  The monitored category was defined as those 
articles that mentioned integrity but did not include a detailed protocol or numerical values to 





treatment integrity because the studies coded as “monitored” touched on the concept of 
integrity but with stated that the information could be found in a different location or claimed 
they had high integrity but provided no proof.  An argument can be made for the fact that 
making an empty claim without solid evidence is a breach of treatment integrity because it is 
impossible to know if the researchers implemented all, some, or none of the aspects of their 
protocol.  We analyzed the monitored category as a branch of the no category because a lack 
of quantitative evidence to prove that a particular protocol has been implemented as intended 
is comparable to a lack of integrity collection entirely.  Gresham, Gansle, and Noell (1993) 
used the monitored category as a way to separate out studies which claimed to include 
procedural integrity checks but had not included the data recorded on this variable.  Figure 5 
shows a graphical representation of the original Gresham data that was reported in the study.  
This figure shows the “yes” and the “no” as two distinct figures in the data, with no overlap.  
Figure 6 shows how the “yes” and the “no” categories remained two distinct categories with 


































Graph of Intergrity Data Reported by 








Figure 6. Graph of the data reported by Gresham , Gansle, and Noell (1993).  This figure 
shows a graphical representation of the percentage data reported as a table (Table 2) in the 
original Gresham study.  The “yes” is the category including all articles within the inclusion 
criteria which provided treatment integrity data.  The studies in the “no” category made no 
mention of integrity data and the “monitored” category included all articles within the 
inclusion criteria that mentioned integrity but provided mo empirical evidence of it.   
 
Figure 7. Graph of the data reported by Gresham , Gansle, and Noell (1993) with the 
no/monitored combined into the “no” category.  This figure shows a graphical representation 
of the percentage data reported as a table in the original Gresham study.  The blue line 
represents the percentage of the total number of studies that reported integrity data.  The red 
line represents the percentage of the total number of studies that did not provide any 
information on treatment integrity in their study or that mentioned integrity data but did not 
provide any 
 
There could be many reasons for this including changes in editorial policies or an 
increase in procedural safeguards such as interobserver agreement. A change in budget or 






































in no integrity data.  If JABA changed their publishing policies or lowered their budget, it 
could have potentially caused authors to shorten the length of their journal articles.  An 
increase in procedural safeguards could also have led to an increase in the lack of integrity 
data provided in studies because researchers could have increased the number of procedural 
safeguards in order to imply integrity but not actually measure integrity itself.  Almost all of 
the studies published in JABA have a section dedicated to inter observer reliability which 
implies a level integrity assessment in these studies despite the fact this it is not an overall 
integrity check for the protocol. 
 The Gresham, Gansle, and Noell study (1993) seemed to have some effect in the 
years surrounding its publication.  Unfortunately, this trend has not spread across the years.  
Interestingly enough, there has been a gradual increase in the “monitored” category which 
could have implications about the long term effects of Gresham’s study.  This gradual 
increase could mean that researchers are becoming more aware of the importance of 
including procedural integrity checks within a study.  Although these studies did not provide 
empirical evidence for the integrity measured from their study, the rise here shows that 
researchers have acknowledged the importance of at least noting integrity.  The “yes” 
category is also gradually rising which shows that many years after the publication of 
Gresham’s study, the importance of collecting and reporting integrity data in behavioral 
studies conducted with children has been noted.  This rise in the “yes” category coincides 
with a gradual decrease in the “no” category.  This combination holds potential for the future 
and suggests that more and more, the importance of reporting integrity data is being 





 Location data also provided interesting information.  The data showed that in all 
home, clinical, and other locations, integrity data was only reported for an average of 28.5% 
of studies while in the school category 41.4% of studies reported integrity data.  This could 
be because there are more safeguards in place in a school setting because there are higher 
levels of distracters when adhering to a protocol in a classroom.  It could also be possible that 
that there is more focus given to studying treatment integrity as it pertains to school based 
treatment protocols, which could be the reason for the school setting to be the only category 
to have a higher level of treatment integrity data present.  For example, the study by Fiske 
(2008) showed the importance of treatment integrity in behavioral protocols implemented by 
teachers and showed a correlation between high integrity and positive outcome.  Also, 
Coding, Livanis, Pace, and Vaca (2008) which studied the importance of treatment integrity 
in providing feedback in the school setting and showed that performance feedback to 
teachers led to high integrity in the academic setting.  It is possible that there was more data 
collection on to integrity in the school setting because researchers need to observe the 
teachers who conducted the sessions to ensure they were correctly following the protocol 
whereas in most other settings, the experimenters themselves are the ones conducting 
sessions.   
With the combined no/monitored category, the results showed that there were still 
more studies that did not report integrity data than there were that did.  This shows that 
location does not have a very strong correlation with the collection of integrity data and 
shows that this is a factor in experimenting which needs to have more attention brought to it.    
Although the presence of disabilities was a variable that as recorded in this study, it 





integrity data presented in a study.  One thing to be noted though, was the significant 
overrepresentation of individuals with disabilities in the data set.  Out of the 652 studies that 
were represented in this study, 491 of the studies included participants with either physical or 
intellectual disabilities.  The overrepresentation of participants with disabilities is a factor 
that should be further analyzed so that a reason for the over representation can be determined.  
One possible explanation could be that ABA treatments often focus on individuals with 
disabilities, so there is more representation of individuals with disabilities across publications 
in JABA.   
Conclusion 
Limitations 
 A potential limitation in this study could be the number of articles included in this 
review.  The criteria for this study was based on the protocol developed by Gresham, Gansle, 
and Noell (1993) and focused solely on studies based on children that were published in 
JABA between the years of 1991 and 2010.  This study provides a small look at integrity data 
but perhaps by expanding the criteria to cover all demographics and encompass other 
journals, more thorough data on the collection of treatment integrity in ABA could be 
reported.  Also, by examining treatment integrity outside of the scope of JABA, more data on 
treatment integrity could be recorded and more information on treatment integrity would be 
known.    
 Furthermore, a major limitation in this study was the lack of integrity data collection, 
both in this research, as well as in the Gresham, Gansle, and Noelle study which this research 





the collection of treatment integrity data, yet it does not provide detail on how integrity was 
maintained in their study.   
Implications 
 The findings of this study may contribute to the realization that there is not nearly a 
strong enough focus on the collection of treatment integrity.  The lack of treatment integrity 
data in the majority of studies done with children implies that there may not be a control 
measure within the protocols of these studies.  This means that some of these studies may not 
be being implemented as planned by the researchers.  
 Treatment integrity is a check of the independent variable.  When confidence is low 
on how the independent variable was presented, then confidence in how the independent 
variable affects the dependent variable is also low.  This means that when the integrity data is 
not consistently reported, there is no strong evidence for determining the relationship 
between the independent and dependent variables.  Treatment integrity also plays a critical 
role in the replication of a study.  Researchers who pay attention to the treatment integrity 
must pay attention to how their independent variables are presented, which in turn forces 
them to specify exactly how their procedures should be presented.  This is very helpful for 
other researchers who wish to replicate that study. 
The results of this study are important to Behavioral Analysis specifically, but also 
can be generalized to any other field of work.  Having high integrity is critical for achieving 
the desired outcome, which is a concept that can apply to any protocol in any area of study.  
All researchers and treatment providers should provide the best treatments they can, and in 
order to do so, it is important that treatment integrity data be collected in order to ensure that 





ABA treatment are consumers and consumers have a right to effective treatment.  The 
treatment that is provided to a consumer is only as good as how effective the treatment is.  
This poses another limitation with the lack of treatment integrity data because consumers 
have a right of high integrity, highly effective treatments. 
This study shows how severe the lack of focus on treatment integrity in Behavioral 
Analysis is, even after the publication of the study by Gresham, Gansle, and Noell (1993) and 
calls to attention the importance for treatment professionals and researchers alike, to support 
high levels of desired outcomes with high treatment integrity and the collection of this data 
during all studies.   
The results of this study are a call to action for researchers everywhere.  The lack of 
treatment integrity data being reported is alarming because the implication here is that  
researchers are following a procedure as published but without the proof that treatment 
integrity data collection provides, there is no way to be 100% certain.  Furthermore, the lack 
of integrity data makes it difficult to replicate a study because it becomes impossible to 
ascertain if the protocol is being implemented correctly when the original study lack data on 
integrity.   
Future Direction 
 The results from this study may lend to the development of future studies.  A major 
future direction could be in the reporting of treatment integrity data in all studies conducted 
with children.  This study focused on articles about children specifically published in JABA, 
but there could be important implications from expanding this study to other journals 





 Second, by addressing the correlation between the location of a study and the 
presence of treatment integrity reporting, a further analysis could be done in order to 
determine the relationship between setting and treatment integrity.  The present study found 
that the only location to be associated with a larger number of studies reporting treatment 
integrity data was the school setting.  One reason for this could be the fact that there is 
researcher supervision in the implementation of protocols by teachers.  In this case, because 
the teachers are also participants in the experimental study, researchers record integrity data 
on the teachers.  In the future, further analysis could examine the relationship between 
treatment integrity and location. 
Finally, in regards to how treatment integrity is reported outside of the field of ABA, 
future studies could demonstrate the extent to which protocols in other fields are being 
conducted as planned.   Treatment integrity is such a critical component for the proper 
implementation of protocols across all fields and it is crucial that the importance of treatment 
integrity becomes generalized across all fields of work.  By assessing studies and protocols 
published in other areas for treatment integrity, better techniques for the evaluation of 
integrity can be developed.  Future studies may develop a successful method for the 
collection and assessment of treatment integrity, which could lead to larger numbers of 
studies across all journals and fields of work providing data on integrity.  In the future, it 
would be helpful to create more awareness for the importance of treatment integrity in 
research and establish prerequisites for publication in journals in which integrity data is a 
requirement for publication.   
 Another factor to research in the future could be the publication requirements and 





or on material could have prevented researchers from publishing specific data on treatment 
integrity.  This research could help determine if there is a lack of focus on the importance of 
treatment integrity or if stringent publication guidelines cause researchers to remove 























Checklist for data collection: 
 
_____ Make sure article is from Journal of Applied Behavior Analysis  between the years of 
1991-2010 
_____ Open articles and first look at the age of participants in the study.  If the age falls 
between the ages of 0-19 years, the study is to be included in the research collection 
_____ Record the age of the participant in the data collection spreadsheet 
_____Next, record if the participants had disabilities (Physical or mental) 
____Then look at the setting that the study was conducted in (Either school, home, clinical, 
or other if it was conducted elsewhere or in a combination of these settings) 
____ Search the article for procedural/treatment integrity/fidelity.  If none of these words 
come up, read the article for mentions of integrity worded other ways, such as “Procedure 
was implemented with a high accuracy”  
 _____If the article provided quantitative evidence for treatment integrity such as the 
percentage with which the integrity was implemented---code the article as “Yes” 
 _____If the article said that they collected treatment integrity or reported a non 
quantifiable measure of integrity (ie the protocol was implemented with high integrity) but 
did not provide any quantitative support for it---code the article as “Monitored” 
 _____If the article did not mention treatment integrity or stated that integrity was not 
collected----code the article as “no” 
____ Lastly, record the type of article.  If it was 3 or less pages code it as brief and if it was 
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